| Ticker Details |
|
Revolution Medicines, Inc.
|
| IPO Date: |
February 13, 2020 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$44.89B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.18 | 2.91%
|
| Avg Daily Range (30 D): |
$3.94 | 2.05%
|
| Avg Daily Range (90 D): |
$4.02 | 2.41%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.05M |
| Avg Daily Volume (30 D): |
1.37M |
| Avg Daily Volume (90 D): |
2.22M |
| Trade Size |
| Avg Trade Size (Sh.): |
68 |
| Avg Trade Size (Sh.) (30 D): |
49 |
| Avg Trade Size (Sh.) (90 D): |
59 |
| Institutional Trades |
| Total Institutional Trades: |
6,752 |
| Avg Institutional Trade: |
$5.19M |
| Avg Institutional Trade (30 D): |
$17.21M |
| Avg Institutional Trade (90 D): |
$14.17M |
| Avg Institutional Trade Volume: |
.09M |
| Avg Institutional Trades (Per Day): |
4 |
| Market Closing Trades |
| Avg Closing Trade: |
$11.8M |
| Avg Closing Trade (30 D): |
$47.82M |
| Avg Closing Trade (90 D): |
$65.92M |
| Avg Closing Volume: |
209.86K |
|
|
| News |
Aug 8, 2026 @ 8:51 PM
ERASCA DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, ...
Source: Rosen Law Firm
|
Aug 7, 2026 @ 7:47 PM
ERASCA LEAD PLAINTIFF DEADLINE AUGUST 10th: Bragar...
Source: Bragar Eagel & Squire, P.C.
|
Aug 7, 2026 @ 7:44 PM
ERAS 3-DAY DEADLINE ALERT: Erasca, Inc. Investors ...
Source: Hagens Berman
|
Aug 6, 2026 @ 2:27 AM
Erasca, Inc. Notice of August 10, 2026 Application...
Source: Hagens Berman Sobol Shapiro Llp
|
Aug 4, 2026 @ 11:55 AM
MONDAY DEADLINE: Robbins Geller Rudman & Dowd LLP ...
Source: Robbins Geller Rudman & Dowd Llp
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
$-8.87
|
$-3.06
|
$-2.29
|
|
Diluted EPS
|
$-8.87
|
$-3.06
|
$-2.29
|
|
Revenue
|
$M
|
$M
|
$M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-1768.29M
|
$-644.37M
|
$-453.82M
|
|
Operating Income / Loss
|
$-1627.25M
|
$-505.13M
|
$-445.22M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$413.94M
|
$374.5M
|
$57.19M
|
|
PE Ratio
|
|
|
|
|
|
|
